CCCC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.55%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

C4 Therapeutics Insider Trading History Chart

C4 Therapeutics Share Price & Price History

^$3.95

▼ -0.1 (-2.47%)

As of 11/21/2024 10:45 AM ET

Days: 30 | 90 | 365

My #1 Pre IPO Trade for 2025 – NAME and TICKER

From Wyatt Investment Research | Ad

One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...

The Next SpaceX Pre-IPO

C4 Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/8/2023	Utpal Koppikar	Director	Buy	5,667	$5.60	$31,735.20	5,667
4/12/2022	Andrew Hirsch	CEO	Buy	10,000	$8.40	$84,000.00	10,000
12/17/2021	Malcolm Salter	Director	Sell	755	$30.25	$22,838.75

Trump said you could learn something from this man

From Wide Moat Research | Ad

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.

SEC Filings (Institutional Ownership Changes) for C4 Therapeutics (NASDAQ:CCCC)

78.81% of C4 Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

C4 Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	243,457	$1.39M	0.0%	+38.4%	0.345%
11/18/2024	Arete Wealth Advisors LLC	73,350	$0.42M	0.0%	-34.1%	0.104%
11/16/2024	Geode Capital Management LLC	1,369,676	$7.81M	0.0%	+0.5%	1.940%
11/15/2024	Vestcor Inc	29,500	$0.17M	0.0%	N/A	0.042%
11/15/2024	M&T Bank Corp	113,907	$0.65M	0.0%	+19.3%	0.161%
11/15/2024	Barclays PLC	243,457	$1.39M	0.0%	+38.4%	0.345%
11/15/2024	XTX Topco Ltd	84,951	$0.48M	0.0%	N/A	0.120%
11/15/2024	Wellington Management Group LLP	286,041	$1.63M	0.0%	+24.7%	0.405%
11/15/2024	Wexford Capital LP	55,231	$0.32M	0.1%	N/A	0.078%
11/15/2024	State Street Corp	2,806,913	$16M	0.0%	-6.3%	3.976%
11/15/2024	Point72 DIFC Ltd	8,873	$51K	0.0%	N/A	0.013%
11/15/2024	Point72 Asset Management L.P.	1,201,848	$6.85M	0.0%	+331.4%	1.703%
11/15/2024	ArrowMark Colorado Holdings LLC	1,319,484	$7.52M	0.1%	+6.0%	1.869%
11/14/2024	Wasatch Advisors LP	5,677,368	$32.36M	0.2%	+17.1%	8.043%
11/14/2024	MetLife Investment Management LLC	35,455	$0.20M	0.0%	+129.1%	0.050%
11/13/2024	Cynosure Group LLC	10,007	$57K	0.0%	N/A	0.014%
11/13/2024	FMR LLC	185,941	$1.06M	0.0%	+687.0%	0.263%
11/13/2024	The Manufacturers Life Insurance Company	41,664	$0.24M	0.0%	+81.8%	0.059%
11/12/2024	Charles Schwab Investment Management Inc.	482,929	$2.75M	0.0%	-1.2%	0.684%
11/9/2024	Intech Investment Management LLC	27,126	$0.16M	0.0%	N/A	0.038%
11/7/2024	LMR Partners LLP	51,000	$0.29M	0.0%	N/A	0.072%
11/6/2024	Cornercap Investment Counsel Inc.	11,791	$67K	0.0%	-56.5%	0.017%
11/5/2024	Aigen Investment Management LP	14,344	$82K	0.0%	N/A	0.020%
11/5/2024	GSA Capital Partners LLP	15,446	$88K	0.0%	-33.6%	0.022%
10/23/2024	Hennion & Walsh Asset Management Inc.	192,364	$1.10M	0.1%	+34.7%	0.280%
10/3/2024	SG Americas Securities LLC	24,941	$0.14M	0.0%	N/A	0.036%
9/16/2024	Cubist Systematic Strategies LLC	560,959	$2.59M	0.0%	-26.7%	0.815%
8/19/2024	Point72 Asset Management L.P.	278,580	$1.29M	0.0%	-69.3%	0.405%
8/19/2024	B. Riley Wealth Advisors Inc.	11,000	$51K	0.0%	N/A	0.016%
8/15/2024	Susquehanna Fundamental Investments LLC	129,801	$0.60M	0.0%	+152.7%	0.189%
8/15/2024	Lynx1 Capital Management LP	6,880,527	$31.79M	11.5%	+89.3%	10.000%
8/15/2024	The Manufacturers Life Insurance Company	22,918	$0.11M	0.0%	-68.3%	0.033%
8/14/2024	Squarepoint Ops LLC	57,117	$0.26M	0.0%	-58.3%	0.083%
8/14/2024	Cubist Systematic Strategies LLC	560,959	$2.59M	0.0%	-26.7%	0.815%
8/14/2024	Profund Advisors LLC	34,149	$0.16M	0.0%	-73.0%	0.050%
8/12/2024	Marathon Trading Investment Management LLC	14,400	$67K	0.0%	-77.5%	0.021%
8/12/2024	E Fund Management Co. Ltd.	11,280	$52K	0.0%	-71.4%	0.016%
8/9/2024	Renaissance Technologies LLC	235,200	$1.09M	0.0%	-42.0%	0.342%
8/9/2024	Dimensional Fund Advisors LP	619,112	$2.86M	0.0%	-2.1%	0.900%
8/8/2024	Cornercap Investment Counsel Inc.	27,136	$0.13M	0.0%	N/A	0.039%
8/8/2024	American Century Companies Inc.	110,075	$0.51M	0.0%	+23.9%	0.160%
8/7/2024	Headlands Technologies LLC	9,652	$45K	0.0%	N/A	0.014%
8/6/2024	Acadian Asset Management LLC	113,436	$0.52M	0.0%	+415.8%	0.165%
8/1/2024	Rhumbline Advisers	90,621	$0.42M	0.0%	+4,959.8%	0.132%
8/1/2024	Hussman Strategic Advisors Inc.	42,000	$0.19M	0.1%	N/A	0.061%
7/26/2024	Bank of New York Mellon Corp	190,761	$0.88M	0.0%	N/A	0.277%
7/20/2024	Hennion & Walsh Asset Management Inc.	142,832	$0.66M	0.0%	N/A	0.208%
5/30/2024	Lynx1 Capital Management LP	3,634,662	$29.70M	7.6%	+16.0%	5.282%
5/24/2024	Farallon Capital Management LLC	28,000	$0.23M	0.0%	N/A	0.041%
5/16/2024	Bain Capital Life Sciences Investors LLC	1,142,210	$9.33M	0.7%	-30.4%	1.660%
5/16/2024	Caxton Associates LP	21,002	$0.17M	0.0%	N/A	0.031%
5/15/2024	Bellevue Group AG	57,600	$0.47M	0.0%	-7.1%	0.084%
5/15/2024	Price T Rowe Associates Inc. MD	2,115,477	$17.28M	0.0%	-17.3%	3.074%
5/14/2024	EntryPoint Capital LLC	28,516	$0.23M	0.2%	N/A	0.041%
5/10/2024	Acadian Asset Management LLC	21,993	$0.18M	0.0%	-87.0%	0.032%
5/10/2024	Vanguard Group Inc.	2,920,028	$23.86M	0.0%	+46.0%	4.244%
5/8/2024	Entropy Technologies LP	15,391	$0.13M	0.0%	N/A	0.022%
5/7/2024	Susquehanna Fundamental Investments LLC	51,365	$0.42M	0.0%	N/A	0.075%
5/7/2024	SG Americas Securities LLC	22,368	$0.18M	0.0%	N/A	0.033%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	41,445	$0.34M	0.0%	N/A	0.060%
4/18/2024	Wasatch Advisors LP	4,328,479	$35.36M	0.2%	-39.4%	6.310%
2/14/2024	Commodore Capital LP	3,800,000	$21.47M	1.9%	N/A	7.711%
2/14/2024	Wasatch Advisors LP	7,138,949	$40.34M	0.2%	+14.3%	14.487%
2/14/2024	Bellevue Group AG	62,000	$0.35M	0.0%	N/A	0.126%
2/14/2024	Lighthouse Investment Partners LLC	21,981	$0.12M	0.0%	N/A	0.045%
2/13/2024	Tower Research Capital LLC TRC	16,322	$92K	0.0%	+33.1%	0.033%
2/2/2024	Headlands Technologies LLC	6,880	$39K	0.0%	N/A	0.014%
1/16/2024	Raymond James & Associates	100,984	$0.57M	0.0%	+10.5%	0.205%
1/12/2024	FNY Investment Advisers LLC	8,800	$49K	0.1%	N/A	0.018%
12/19/2023	Public Employees Retirement System of Ohio	71,163	$0.13M	0.0%	-65.7%	0.144%
12/6/2023	Citigroup Inc.	57,894	$0.11M	0.0%	+214.6%	0.117%
11/14/2023	Lynx1 Capital Management LP	1,019,230	$1.90M	1.3%	N/A	2.068%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	164,722	$0.31M	0.0%	-5.5%	0.334%
11/13/2023	Algert Global LLC	51,760	$96K	0.0%	-12.4%	0.105%
11/13/2023	Acadian Asset Management LLC	28,014	$51K	0.0%	-78.1%	0.057%
11/7/2023	Barclays PLC	43,614	$81K	0.0%	+30.7%	0.089%
11/2/2023	M&T Bank Corp	140,020	$0.26M	0.0%	N/A	0.285%
10/24/2023	Raymond James & Associates	91,380	$0.17M	0.0%	+8.5%	0.186%
10/20/2023	Harbor Capital Advisors Inc.	70,703	$0.13M	0.0%	+20.6%	0.144%
9/21/2023	Barclays PLC	33,368	$92K	0.0%	-29.5%	0.068%
8/14/2023	ArrowMark Colorado Holdings LLC	309,755	$0.85M	0.0%	-95.1%	0.630%
8/14/2023	TCG Crossover Management LLC	1,276,574	$3.51M	0.6%	+2.1%	2.595%
8/14/2023	Prelude Capital Management LLC	34,000	$94K	0.0%	N/A	0.069%
8/14/2023	Graham Capital Management L.P.	32,974	$91K	0.0%	N/A	0.067%
8/11/2023	Pale Fire Capital SE	19,200	$53K	0.0%	N/A	0.039%
8/11/2023	B. Metzler seel. Sohn & Co. AG	66,276	$0.18M	0.0%	+265.8%	0.135%
8/8/2023	Wasatch Advisors LP	7,199,491	$19.80M	0.1%	+26.0%	14.675%
8/7/2023	Acadian Asset Management LLC	128,060	$0.35M	0.0%	N/A	0.261%
7/25/2023	Raymond James & Associates	84,234	$0.23M	0.0%	+33.5%	0.172%
7/11/2023	Harbor Capital Advisors Inc.	58,647	$0.16M	0.0%	+10.1%	0.120%
7/10/2023	SG Americas Securities LLC	12,810	$35K	0.0%	-54.3%	0.026%
5/12/2023	Martingale Asset Management L P	39,420	$0.12M	0.0%	+20.6%	0.080%
5/11/2023	M&T Bank Corp	72,000	$0.23M	0.0%	+17.5%	0.147%
5/11/2023	Cornercap Investment Counsel Inc.	48,047	$0.15M	0.0%	+82.8%	0.098%
5/10/2023	B. Metzler seel. Sohn & Co. AG	18,120	$57K	0.0%	N/A	0.037%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	113,893	$0.36M	0.0%	+687.8%	0.232%
5/9/2023	Y Intercept Hong Kong Ltd	31,362	$98K	0.0%	N/A	0.064%
4/28/2023	SG Americas Securities LLC	28,013	$88K	0.0%	-32.6%	0.057%
4/26/2023	Harbor Capital Advisors Inc.	53,278	$0.17M	0.0%	+113.7%	0.109%
2/14/2023	Alpine Global Management LLC	18,574	$0.11M	0.0%	N/A	0.038%

Data available starting January 2016

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma, currently under Phase 1/2 clinical trials. The company is also developing CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies, currently under Phase 1/2 clinical trials; and CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC. It has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; Betta Pharmaceuticals, Co., Ltd.; and Merck Sharp & Dohme, LLC, as well as Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $3.95

$3.95

$4.07

50 Day Range

MA: $5.77

$4.05

$7.00

52 Week Range

Now: $3.95

$1.06

$11.88

Volume

8,863 shs

Average Volume

2,104,678 shs

Market Capitalization

$278.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.04

Who are the company insiders with the largest holdings of C4 Therapeutics?: C4 Therapeutics' top insider shareholders include:
Utpal Koppikar (Director)
Learn More about top insider investors at C4 Therapeutics.
Who are the major institutional investors of C4 Therapeutics?: C4 Therapeutics' top institutional investors include:
Wasatch Advisors LP — 8.04%
State Street Corp — 3.98%
Geode Capital Management LLC — 1.94%
ArrowMark Colorado Holdings LLC — 1.87%
Point72 Asset Management L.P. — 1.70%
Charles Schwab Investment Management Inc. — 0.68%
Learn More about top institutional investors of C4 Therapeutics stock.
Which major investors are selling C4 Therapeutics stock?: In the last quarter, CCCC stock was sold by these institutional investors:
State Street Corp
Arete Wealth Advisors LLC
Cornercap Investment Counsel Inc.
GSA Capital Partners LLP
Charles Schwab Investment Management Inc.
Which major investors are buying C4 Therapeutics stock?: In the previous quarter, CCCC stock was bought by institutional investors including:
Point72 Asset Management L.P.
Wasatch Advisors LP
FMR LLC
XTX Topco Ltd
ArrowMark Colorado Holdings LLC
Barclays PLC
Barclays PLC
Wellington Management Group LLP